Vortioxetine

Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study

Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia

RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)

Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)

Vortioxetine for Newly Diagnosed Glioblastoma

THINC-it Vortioxetine - Sensitivity to Change

Vortioxetine for Post-COVID-19 Condition

Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea

Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation

Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia

Adjunctive Vortioxetine in Schizophrenia

Vortioxetine Adjunctive Treatment in Bipolar Depression

Using 18F-FPEB PET to Identify mGLUR5 Availability in Affective Disorders

Substance Misuse To Psychiatric Disorders for Cannabis

Tolerability, Safety and Efficacy of Vortioxetine

Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment

Vortioxetine to Prevent Return of Symptoms in Children With Depression

Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age

Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes

Vortioxetine in Patients With Depression and Early Dementia